81 – 100 of 144
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Factors associated with perceived walking difficulties in people with Parkinson’s disease
(
- Contribution to journal › Published meeting abstract
-
Mark
The Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale for use in Sweden
2017) 21st International Congress of Parkinson's Disease and Movement Disorders(
- Contribution to conference › Abstract
-
Mark
Factors Contributing to Perceived Walking Difficulties in People with Parkinson’s Disease
(
- Contribution to journal › Article
-
Mark
Factors associated with perceived walking difficulties in people with Parkinson’s disease
2017) 21st International Congress of Parkinson's Disease and Movement Disorders(
- Contribution to conference › Abstract
-
Mark
Levodopa effect and motor function in late stage Parkinson’s disease
(
- Contribution to conference › Abstract
-
Mark
Workforce unavailability in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Distribution and impact on quality of life of the pain modalities assessed by the King's Parkinson's disease pain scale
(
- Contribution to journal › Article
-
Mark
Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?
(
- Contribution to journal › Scientific review
-
Mark
Levodopa-carbidopa intestinal gel in advanced Parkinson's : Final results of the GLORIA registry
(
- Contribution to journal › Article
-
Mark
A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement
(
- Contribution to journal › Article
- 2016
-
Mark
Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Oral and infusion levodopa therapy in the management of Parkinson’s disease
2016) p.63-75(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Non-oral Continuous Drug Delivery Techniques in Parkinson's Disease : For Whom, When, and How?
(
- Contribution to journal › Scientific review
-
Mark
Continuous dopaminergic stimulation therapy for Parkinson's disease - Recent advances
(
- Contribution to journal › Article
-
Mark
Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Perceived walking difficulties in relation to motor aspects in Parkinson’s disease
2016) 4th World Parkinson Congress(
- Contribution to conference › Abstract
-
Mark
Life satisfaction in Parkinson's disease - associated factors
2016) The 20th International Congress of Parkinson's Disease and Movement Disorders(
- Contribution to conference › Abstract
-
Mark
Non-oral dopaminergic therapies for Parkinson's disease : current treatments and the future
(
- Contribution to journal › Scientific review
-
Mark
Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Integrated Safety of Levodopa-Carbidopa Intestinal Gel From Prospective Clinical Trials.
(
- Contribution to journal › Article